To further assess the effect of MEK1/2 and CDK4 on the growth of ESCC, we respectively generated cell lines with MEK1, MEK2, or CDK4 knockdown (Fig. 5A). This evidence concerns the gene MAP2K1 and esophageal squamous cell carcinoma.